Inogen (INGN) Profit After Tax (2013 - 2026)
Inogen's (INGN) quarterly Profit After Tax came in at -$4.2 million in Q2 2026, down 0.89% year-over-year from -$4.2 million in Q2 2025, and up 54.23% quarter-over-quarter from -$9.2 million in Q1 2026.
Analysis
Inogen (INGN) Profit After Tax (2013 - 2026) Analysis & Trends
Inogen (INGN) has reported Profit After Tax for 14 consecutive years, with -$4.2 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Profit After Tax fell 0.89% year-over-year to -$4.2 million in Q2 2026; TTM through Jun 2026 was -$25.8 million, a 10.46% increase from a year earlier, with the FY2025 full-year figure at -$22.7 million, up 41.09% from the prior year.
- Profit After Tax was -$4.2 million for Q2 2026 at Inogen, up from -$9.2 million in the prior quarter.
- Over five years, Profit After Tax peaked at -$4.2 million in Q2 2025 and troughed at -$56.4 million in Q4 2022.
- A 5-year average of -$14.7 million and a median of -$9.5 million in 2023 frame the typical range for Profit After Tax.
- Across the five-year window, Profit After Tax plunged 1880.74% in 2022 and surged 87.14% in 2024, its largest moves.
- Over 5 years, Profit After Tax stood at -$56.4 million in 2022, then soared by 53.54% to -$26.2 million in 2023, then surged by 52.38% to -$12.5 million in 2024, then jumped by 42.91% to -$7.1 million in 2025, then soared by 41.22% to -$4.2 million in 2026.
- The last three Profit After Tax figures came in at -$4.2 million (Q2 2026), -$9.2 million (Q1 2026), and -$7.1 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.14 Bn | 177.54 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Intuitive Surgical | 125.03 Bn | 119.81 Bn | 1.96 Bn | 823.20 Mn |
| 3 | Medtronic | 117.95 Bn | 109.13 Bn | 6.34 Bn | 1.48 Bn |
| 4 | Stryker | 105.45 Bn | 101.97 Bn | 4.50 Bn | 1.28 Bn |
| 5 | Boston Scientific | 66.16 Bn | 65.62 Bn | 3.85 Bn | 905.00 Mn |
| 6 | Edwards Lifesciences | 49.54 Bn | 45.29 Bn | 1.35 Bn | 241.90 Mn |
| 7 | Alcon | 33.69 Bn | 32.23 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.03 Bn | 30.08 Bn | 830.00 Mn | 249.10 Mn |
| 9 | Steris | 21.01 Bn | 20.53 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Inogen | 142.66 Mn | 37.12 Mn | 43.27 Mn | -4.19 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -4.19 Mn |
| Mar 31, 2026 | -9.15 Mn |
| Dec 31, 2025 | -7.13 Mn |
| Sep 30, 2025 | -5.29 Mn |
| Jun 30, 2025 | -4.15 Mn |
| Mar 31, 2025 | -6.17 Mn |
| Dec 31, 2024 | -12.48 Mn |
| Sep 30, 2024 | -5.96 Mn |
| Jun 30, 2024 | -5.92 Mn |
| Mar 31, 2024 | -15.62 Mn |
| Dec 31, 2023 | -26.22 Mn |
| Sep 30, 2023 | -46.38 Mn |
| Jun 30, 2023 | -9.83 Mn |
| Mar 31, 2023 | -20.35 Mn |
| Dec 31, 2022 | -56.42 Mn |
| Sep 30, 2022 | -9.90 Mn |
| Jun 30, 2022 | -4.67 Mn |
| Mar 31, 2022 | -14.50 Mn |
| Dec 31, 2021 | -24.05 Mn |
| Sep 30, 2021 | 12.52 Mn |